Muken Ross 4
Research Summary
AI-generated summary
SOPHiA GENETICS (SOPH) President Muken Ross Sells 1,183 Shares
What Happened Muken Ross, President of SOPHiA GENETICS SA (SOPH), sold 1,183 shares on March 19, 2026, for a reported weighted-average price of $4.79 per share, totaling $5,671 (disposition). This was a sale (not a purchase) and appears to be a routine, tax-related disposition rather than a discretionary trade.
Key Details
- Transaction date: 2026-03-19; Filing date: 2026-03-20 (filed timely).
- Shares sold: 1,183; Weighted-average price reported: $4.79; Total proceeds: $5,671.
- Price range: shares were sold in multiple trades at prices between $4.69 and $4.87 (per footnote).
- Reason/footnotes: Sale was to satisfy tax obligations tied to RSU vesting on 2026-03-18 and was effected under a pre-established Rule 10b5-1 trading plan (non-discretionary).
- Shares owned after the transaction: not disclosed in the provided filing excerpt.
Context
- This sale was tax withholding related to restricted stock unit vesting and executed under a 10b5-1 plan—common, routine insider transactions that do not necessarily signal a change in the insider's view on the company.
- The dollar amount is small relative to typical insider trades; purchases (not present here) are generally more informative about insider sentiment.